Expanding The Boundaries of Precision Medicine: Accelerating Lipid Nanoparticle Innovation
Master the strategies to propel lipid nanoparticles from development to market: Pioneer targeted delivery, manufacturing scalability and unlock therapeutic breakthroughs for LNPs.
What to Expect at LNPs Europe 2026
500+
Global Attendees across the co-located Cell and Gene Therapy International Europe and Exosomes Europe Events
30+
LNPs Expert Speakers
3
Co-located Events
12+
Hours of Networking with LNP Industry Professionals
Revolutionising Drug Delivery: Scalable Solutions and New Therapeutic Frontiers
LNPs Europe is a premier platform for researchers and biopharmaceutical innovators to advance lipid nanoparticles (LNPs) as non-viral delivery systems and therapeutics.
Co-located with Cell and Gene Therapy International Europe and Exosomes Europe, the summit will host 500+ global attendees, promoting collaboration and sharing cutting-edge methods in non-viral and viral vector delivery. Attendees will explore breakthroughs in tissue-specific targeting, scalable manufacturing, advanced characterisation, and next-generation LNPs, driving safer, more effective solutions for precision medicine and drug delivery.
Success Stories and Solutions from Lipid Nanoparticles Leaders
LNPs Europe bring together industry leaders shaping the future of lipid nanoparticles as non-viral delivery systems and therapeutics. Our early-confirmed speakers are just the beginning of a world-class faculty pushing the industry forwards.
Mapping the Road from Cutting-Edge Discoveries to Commercial Success for Lipid Nanoparticles
Explore the key themes shaping LNPs Europe 2026, crafted to help attendees navigate the full spectrum on LNP development.
Extrahepatic Targeting Strategies for Efficient Delivery Beyond the Liver
Explore breakthrough engineering approaches for organ and cell-specific LNP delivery through surface-conjugated targeting, ionisable lipid optimisation, and formulation innovations to expand LNP delivery beyond hepatic tissues.
Increasing Efficiency, Reducing Costs & Scalable Solutions for LNP Manufacturing
Optimise LNP process development and manufacturing through expert insights on cost reduction strategies, scale-up optimisation, batch consistency, sustainable processing from early development through large-scale commercial production.
Innovative Analytics & Characterisation Strategies for Lipid Nanoparticles Development
Leverage emerging analytical technologies to characterise complex LNP cargos, overcome current methodological limitations, and meet regulatory expectations through cutting-edge approaches to product quality attributes.
R&D Innovations: Next-Generation Therapeutic Applications of LNPs
Discover cutting-edge LNP applications beyond vaccines through case studies showcasing RNA and DNA delivery for oncology, protein replacement, gene editing, chronic and rare diseases.
In Vivo CAR-T LNPs: Clinical Development & Scale-Up Solutions
Master ligand design, manufacturing, regulatory, and delivery strategies to scale in vivo CAR-T therapies from concept to clinical reality.
Navigating the Evolving Regulatory Landscape for LNPs
Gain critical insights into LNP regulatory assessment frameworks, and submission expectations while understanding unique quality, safety, and efficacy requirements to successfully advance your LNP products through approval pathways.
Engage a Qualified Audience of Lipid Nanoparticles (LNPs) Decision-Makers
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your sales and marketing goals.
Contact Roshni Shah to learn more about sponsorship opportunities: roshni.shah@informa.com
Upcoming Related Events
FAQs
When and where is LNPs Europe 2026 taking place?
LNPs Europe 2026 will be held on 3-5 November 2026 in Berlin, Germany. The event will be co-located with Cell and Gene Therapy International Europe and Exosomes Europe, offering a unique combined experience.
Who organises LNPs Europe?
LNPs Europe is organized by Informa Connect, a division of Informa PLC. Find out more about Informa’s Life Science events here.
What topics will be covered at LNPs Europe 2026?
The event will focus on key themes shaping the development and production of lipid nanoparticles (LNPs), including:
- Extrahepatic targeted delivery
- Scalable manufacturing and cost reduction strategies
- Advanced analytical methodologies for LNP characterisation
- Formulation, stability, and storage solutions
- Next-generation LNPs and combination therapies
- Biodistribution, clearance, and encapsulation efficiency
- Sustainability in LNP production
- Navigating global regulatory landscapes
Are there sponsorship opportunities available?
Yes, LNPs Europe 2026 offers tailored sponsorship opportunities to help companies raise their profile, launch new products, and develop business connections. For more information, contact Roshni Shah at roshni.shah@informa.com
What networking and digital features are available at the event?
Attendees can benefit from:
- Over 12 hours of networking with industry professionals
- The ConnectMe app for seamless digital engagement, including meeting scheduling and real-time agenda updates
- Access to co-located events (Cell and Gene Therapy International Europe and Exosomes Europe) for triple the content and connections
Can I submit a poster presentation?
Yes, attendees are encouraged to submit scientific posters to showcase their latest research. Posters will be displayed during the event, providing an opportunity to gain industry recognition and connect with leading experts in the LNP community. More information about the poster submission process will be shared soon.